Revenue
2018
2019
2020
2021
2022
2023
2024
2025
Syndax Pharmaceuticals Inc (SNDX)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2017
2018
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $172.4M | $23.7M | $0 | $0 | $139.7M | $1.5M | $1.5M | $1.5M | $2.1M | $1.2M | $627,000 | — |
| Research & development | $258.8M | $241.6M | $163.0M | $118.5M | $88.2M | $50.4M | $43.0M | $60.1M | $48.2M | $31.7M | $9.5M | $10.2M |
| Operating expenses | $445.4M | $363.4M | $230.0M | $151.8M | $113.5M | $72.9M | $59.1M | $77.4M | $64.1M | $45.0M | $21.1M | $21.3M |
| Operating income | −$273.1M | −$339.7M | −$230.0M | −$151.8M | $26.2M | −$71.4M | −$57.5M | −$75.9M | −$62.0M | −$43.8M | −$20.5M | −$21.3M |
| Net income | −$285.4M | −$318.8M | −$209.4M | −$149.3M | $24.9M | −$73.2M | −$56.0M | −$74.0M | −$60.8M | −$44.5M | −$24.1M | −$19.8M |
| Basic EPSper diluted share | -$3.29 | -$3.72 | -$2.98 | -$2.46 | $0.48 | -$1.87 | -$1.84 | -$2.92 | -$2.90 | -$3.22 | -$1,519.27 | -$453.02 |
| Diluted EPSper diluted share | -$3.29 | -$3.72 | -$2.98 | -$2.46 | $0.46 | -$1.87 | -$1.84 | -$2.92 | -$2.90 | -$3.22 | -$1,519.27 | -$453.02 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 12, 2026Form 4 · 10b5-1 | Botwood Nicholas A.J.Head of R&D, CMO | SellCommon Stock | 31.2K | $18.14 | $566.6K | 60.9K |
| Jun 11, 2026Form 4 · 10b5-1 | Botwood Nicholas A.J.Head of R&D, CMO | SellCommon Stock | 34.3K | $18.00 | $617.0K | 60.9K |
| Jun 1, 2026Form 4 | Goldan Keith A.Chief Financial Officer | SellCommon Stock | 1.2K | $18.99 | $22.4K | 139.3K |
| Jun 1, 2026Form 4 | Metzger Michael AChief Executive Officer | SellCommon Stock | 6.8K | $18.99 | $130.0K | 484.8K |
| Feb 9, 2026Form 4 | Metzger Michael AChief Executive Officer | SellCommon Stock | 17.2K | $21.03 | $360.9K | 491.7K |